These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6186056)
1. Development of suppressor T cells by antilymphocyte serum treatment in mice. Maki T; Simpson M; Monaco AP Transplantation; 1982 Dec; 34(6):376-81. PubMed ID: 6186056 [TBL] [Abstract][Full Text] [Related]
2. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells. Maki T; Gottschalk R; Wood ML; Monaco AP J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692 [TBL] [Abstract][Full Text] [Related]
3. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow. Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905 [TBL] [Abstract][Full Text] [Related]
5. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus. Fukuzaki T; Hancock WW; Monaco AP; Maki T Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862 [TBL] [Abstract][Full Text] [Related]
6. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice. Wood ML; Monaco AP Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture. De Fazio SR; Monaco AP; Gozzo JJ Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127 [No Abstract] [Full Text] [Related]
8. Increase in neonatal suppressor cell activity resulting from the graft-versus-host reaction. Argyris BF Transplantation; 1984 Sep; 38(3):247-51. PubMed ID: 6236590 [TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts. Maki T; Gottschalk R; Homsy FN; Okazaki H; Wood ML; Monaco AP Transplant Proc; 1981 Mar; 13(1 Pt 1):596-8. PubMed ID: 6455803 [No Abstract] [Full Text] [Related]
10. Spleen cells from adult mice given total lymphoid irradiation (TLI) or from newborn mice have similar regulatory effects in the mixed leukocyte reaction (MLR). II. Generation of antigen-specific suppressor cells in the MLR after the addition of spleen cells from newborn mice. Okada S; Strober S J Immunol; 1982 Nov; 129(5):1892-7. PubMed ID: 6181149 [TBL] [Abstract][Full Text] [Related]
11. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923 [TBL] [Abstract][Full Text] [Related]
12. Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow. Takahashi T; Mafune K; Maki T J Exp Med; 1990 Sep; 172(3):901-9. PubMed ID: 2143775 [TBL] [Abstract][Full Text] [Related]
13. Proliferative and cytotoxic immune functions in aging mice. II. Decreased generation of specific suppressor cells in alloreactive cultures. Gottesman SR; Walford RL; Thorbecke GJ J Immunol; 1984 Oct; 133(4):1782-7. PubMed ID: 6206137 [TBL] [Abstract][Full Text] [Related]
14. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Ohzato H; Monaco AP Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774 [TBL] [Abstract][Full Text] [Related]
15. Mixed lymphocyte reactivity in spleen cells from F-9 tumor-bearing ice. I. Suppressor cell induction and characterization. Bluestone JA; Lopez C; Hurtenbach U Cell Immunol; 1981 Aug; 62(2):334-40. PubMed ID: 6456820 [No Abstract] [Full Text] [Related]
16. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA; Gottschalk R; Maki T; Monaco AP Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619 [TBL] [Abstract][Full Text] [Related]
17. Regulatory mechanisms in cell-mediated immune responses. VIII. Differential expression of I-region determinants by suppressor cells and their targets in suppression of mixed leukocyte reactions. Rich SS; David CS J Exp Med; 1979 Nov; 150(5):1108-21. PubMed ID: 91654 [TBL] [Abstract][Full Text] [Related]
18. Nonspecific suppression of anti-graft immunity by antigen-specific T suppressor cells. Bianchi AT; Hussaarts-Odijk LM; Benner R Adv Exp Med Biol; 1982; 149():651-8. PubMed ID: 6183938 [TBL] [Abstract][Full Text] [Related]
19. Generation of cytotoxic T lymphocytes in vitro. VII. Suppressive effect of irradiated MLC cells on CTL response. Fitch FW; Engers HD; Cerottini JC; Bruner KT J Immunol; 1976 Mar; 116(3):716-23. PubMed ID: 56399 [TBL] [Abstract][Full Text] [Related]
20. T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion. Gorczynski RM; Boulanger M; Lau C J Immunol; 1987 May; 138(10):3197-202. PubMed ID: 2952712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]